Michael Astrue
2013
In 2013, Michael Astrue earned a total compensation of $372.5K as Former Interim Chief Executive Officer at InVivo Therapeutics Holdings.
Compensation breakdown
| Salary | $138,461 |
|---|---|
| Stock Awards | $234,023 |
| Total | $372,484 |
Astrue received $234K in stock awards, accounting for 63% of the total pay in 2013.
Astrue also received $138.5K in salary.
Rankings
In 2013, Michael Astrue's compensation ranked 10,266th out of 12,286 executives tracked by ExecPay. In other words, Astrue earned more than 16.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,266 out of 12,286 | 16th |
Division Manufacturing | 3,814 out of 4,612 | 17th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 535 out of 677 | 21st |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 324 out of 416 | 22nd |
Industry Surgical and Medical Instruments and Apparatus | 200 out of 259 | 23rd |
Source: SEC filing on April 29, 2015.
Astrue's colleagues
We found five more compensation records of executives who worked with Michael Astrue at InVivo Therapeutics Holdings in 2013.
2013
Brian Hess
InVivo Therapeutics Holdings
Chief Technology Officer
2013
Frank Reynolds
InVivo Therapeutics Holdings
Chief Executive Officer
2013
Sean Moran
InVivo Therapeutics Holdings
Chief Financial Officer
2013
Gregory Perry
InVivo Therapeutics Holdings
Chief Financial Officer
2013
Steven McAllister
InVivo Therapeutics Holdings